Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myoblast Transplantation in Duchenne Muscular Dystrophy
NCT02196467Phase 2Unknown
- Sponsor
- CHU de Québec-Université Laval
- Start
- May 2014
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) (2 arms), sponsored by CHU de Québec-Université Laval. Primary endpoint: Number of Participants with Serious and Non-Serious Adverse Events at 6 months. Status: unknown.
02
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT02196467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02196467.